On Friday, H.C. Wainwright maintained a Buy rating on shares of Corcept Therapeutics (NASDAQ:CORT) and significantly raised the price target from $45.00 to $80.00. The firm's decision reflects a ...
The firm increased the price target for HEICO shares to $282 from the previous $264, while maintaining a Buy rating ... Tips reveal that HEICO has raised its dividend for 7 consecutive years ...
Read more about Cryptonews With $1.6 million raised, RIA once again blazes through its presale. Is now a good time to buy RIA? Early this month, the Calvaria developers announced that the native token ...